• 1
    Jones A. W. Age- and gender-related differences in blood amphetamine concentrations in apprehended drivers: lack of association with clinical evidence of impairment. Addiction 2007; 102: 108591.
  • 2
    Gustavsen I., Mørland J., Bramness J. G. Impairment related to blood amphetamine and/or methamphetamine concentrations in suspected drugged drivers. Accid Anal Prev 2006; 38: 4905.
  • 3
    Bramness J., Skurtveit S., Morland J. Clinical impairment of benzodiazepines—relation between benzodiazepine concentrations and impairment in apprehended drivers. Drug Alcohol Depend 2002; 68: 13141.
  • 4
    Bramness J., Skurtveit S., Mørland J. Impairment due to intake of carisoprodol. Drug Alcohol Depend 2004; 74: 31118.
  • 5
    Bachs L., Høiseth G., Skurtveit S., Mørland J. Heroin-using drivers: importance of morphine and morphine-6-glucoronide on late clinical impairment. Eur J Clin Pharmacol 2006; 62: 90512.
  • 6
    Skurtveit S., Abotnes B., Christophersen A. S. Drugged drivers in Norway with benzodiazepine detections. Forensic Sci Int 2002; 125: 7582.
  • 7
    Christophersen A. S., Skurtveit S., Grung M., Morland J. Rearrest rates among Norwegian drugged drivers compared with drunken drivers. Drug Alcohol Depend 2002; 66: 8592.
  • 8
    Skurtveit S., Christophersen A. S., Grung M., Morland J. Increased mortality among previously apprehended drunken and drugged drivers. Drug Alcohol Depend 2002; 68: 14350.
  • 9
    Jones A. W. Driving under the influence of drugs in Sweden with zero concentration limits in blood for controlled substances. Traffic Inj Prev 2005; 6: 31722.